Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
SAN DIEGO, July 14, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi). This includes validation of Illumina's corporate greenhouse gas (GHG) emissions reduction targets by the organization.
- The SBTi is a global body that enables businesses to set ambitious emissions reduction targets in line with the latest climate science.
- "Illumina proudly joins the SBTi as the first genomics company in the world with a verified, science-based, net-zero target," said John Frank, Chief Public Affairs Officer of Illumina.
- In January 2022, it opened this certification to all companies, and Illumina was among the first to request verification of its net-zero target.
- Now, Illumina is among the first group of companies in the world to receive validation of its science-based targets.